Evolution of Ocular Growth in Myopic Children: a Prospective Cohort Study

Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Mar 19, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Evolution of Ocular Growth in Myopic Children," aims to better understand how myopia, or nearsightedness, develops in children living in Europe. Myopia is a growing concern, with millions affected worldwide, and it can lead to serious vision problems if it worsens. The study plans to gather detailed information and images of the eyes of myopic children to see how their eyes grow over time, which could help develop better treatments and preventive measures.

To participate in this study, children aged between 2 and 6 years who have myopia in at least one eye can be eligible, provided they have the consent of a parent or guardian. Participants will undergo eye exams and imaging to track changes in their eye growth. It's important to note that children with certain eye injuries, surgeries, or specific health conditions will not be included in this study. The information gathered from this trial could be vital in addressing the rising rates of myopia in Europe, especially in places like France.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Myopia in at least one eye, defined as a refractive error in spherical equivalent ≤ -0.50 diopters (autorefraction under cycloplegia)
• • Affiliated or beneficiary of a social security system
• • Explicit consent from a holder of parental authority
• Exclusion Criteria:
• • Presence of trauma in both eyes
• • Presence of inflammatory conditions in both eyes
• • History of intraocular surgery (cataract, filtering surgery, intra-vitreal surgery) in both eyes
• • Patient benefiting from legal protection measures